Crossmark

Clinical outcomes and treatment approach for community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in Israel

Crossref DOI link: https://doi.org/10.1007/s10096-016-2789-3

Published Online: 2016-09-27

Published Print: 2017-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Berla-Kerzhner, E.

Biber, A.

Parizade, M.

Taran, D.

Rahav, G.

Regev-Yochay, G.

Glikman, D.
Funding

Funding for this research was provided by:

Office of the Chief Scientist, Ministry of Health (3-7599)

Office of the Chief Scientist, Ministry of Health (3-7599)
License Information

License valid from 2016-09-27